PRESS RELEASE published on 04/25/2025 at 07:00, 1 year ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report covering the first three months of 2025 revealing a net loss of CHF 241 mn. More information at report.bbbiotech.ch/Q125 Financial Results Investment Company BB Biotech AG Interim Report Business Activities
PRESS RELEASE published on 04/25/2025 at 07:00, 1 year ago BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility BB Biotech AG reports net loss in Q1 2025 due to market volatility. Portfolio focus on innovative biotech companies above USD 1 bn. Details on exits and regulatory milestones Market Volatility BB Biotech AG Biotech Companies Q1 2025 Portfolio Focus
BRIEF published on 03/19/2025 at 17:50, 1 year 1 month ago BB Biotech AG Shareholders Approve Dividend and Re-Elect Board Investment Strategy Dividend Board Re-election BB Biotech AGM 2025
PRESS RELEASE published on 03/19/2025 at 17:45, 1 year 1 month ago Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 1.80 per share Shareholders at BB Biotech AG’s AGM approve dividend of CHF 1.80 per share and all board proposals. Re-elected board members for another term Shareholders Dividend AGM BB Biotech AG Board Proposals
BRIEF published on 02/21/2025 at 07:05, 1 year 2 months ago BB Biotech AG Releases 2024 Annual Report Dividend Proposal Net Profit BB Biotech AG Biotechnology Sector 2024 Annual Report
BRIEF published on 02/21/2025 at 07:05, 1 year 2 months ago BB Biotech Navigates Biotech Sector's Early Recovery in 2024 Investment Strategy 2024 Financial Performance BB Biotech Regulatory Milestones Biotech Recovery
PRESS RELEASE published on 02/21/2025 at 07:00, 1 year 2 months ago EQS-Adhoc: BB Biotech AG publishes its 2024 annual report BB Biotech AG publishes its 2024 annual report, revealing financial performance and proposed dividend. Report includes biotech sector overview and investment details Biotechnology Investment Dividend BB Biotech AG 2024 Annual Report
PRESS RELEASE published on 02/21/2025 at 07:00, 1 year 2 months ago Annual Report 2024: BB Biotech positions for structural sector recovery amid shifting market dynamics BB Biotech's 2024 Annual Report highlights the company's strategic positioning for sector recovery amid shifting market dynamics, including key milestones and financial results Annual Report Investment Performance Sector Recovery Market Dynamics BB Biotech
BRIEF published on 01/24/2025 at 07:05, 1 year 3 months ago BB Biotech: 2024 Results and Dividend Proposal Overview Dividend Proposal Biotech Sector BB Biotech Investor Sentiment 2024 Results
BRIEF published on 01/24/2025 at 07:05, 1 year 3 months ago BB Biotech AG Reports Profit in 2024 Fiscal Year Financial Results Investment Performance BB Biotech AG 2024 Fiscal Profit Drug Developers
Published on 05/04/2026 at 01:40, 1 hour 18 minutes ago New Head of Corporate Affairs and Sustainability
Published on 05/02/2026 at 21:00, 1 day 5 hours ago GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 2 days 1 hour ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 2 days 2 hours ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 2 days 2 hours ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/03/2026 at 20:10, 6 hours 48 minutes ago A Decade of Learning Across Borders: PKU's South-South Institute Turns 10
Published on 05/03/2026 at 04:45, 22 hours 13 minutes ago GWM Unveils World-Class Safety & Testing Facilities: Safety Built on Data, Not Hype
Published on 05/02/2026 at 15:35, 1 day 11 hours ago Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 2 days 7 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/30/2026 at 20:00, 3 days 6 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 3 days 7 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 3 days 7 hours ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 3 days 8 hours ago Minutes of the Combined General Meeting held on April 30, 2026
